© 2002 Journal of Medical Genetics
LETTER TO JMG
Genome screening of coeliac disease
1 Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, UK
2 University Children's Hospital, Steinwiesstrass 75, Zurich, Switzerland
3 Kinderpoliklinik, Eberhard-Karls-Universitat, Tubingen, Germany
4 Gastroenterology and Liver Unit, St Vincent's Hospital, Dublin, Ireland
5 Department of Paediatrics, Linkoping University, Sweden
6 Gastroenterology Unit, The Radcliffe Infirmary, Oxford, UK
7 Department of Paediatrics, Norrkoping Hospital, Sweden
8 Department of Medicine, Derbyshire Royal Infirmary, Derby, UK
9 University Surgical Unit, Northern General Hospital, Sheffield, UK
10 Division of Medicine, St James's University Hospital, Leeds, UK
11 Department of Child Health, University Hospital of Wales, Cardiff, UK
12 Department of Gastroenterology, Belfast City Hospital Trust, Belfast, UK
13 Department of Clinical Medicine, Trinity Centre, St James' Hospital, Dublin, Ireland
14 Department of Gastroenterology, St Bartholomew's Hospital, London, UK
15 Department of Public Health and Epidemiology, University Hospital, Nottingham, UK
16 University Department of Medicine, Hope Hospital, Salford, Manchester, UK
17 Hepatogastroenterology, Rijnstate Hospital, Arnhem, The Netherlands
18 Department of Medicine, University of Lund, Malmo, Sweden
19 University Department of Paediatric Gastroenterology, Royal Free Hospital, London, UK
Correspondence to:
Correspondence to:
Dr S Popat, Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, UK;
s.popat@icr.ac.uk
Keywords: coeliac disease; genome screening
Coeliac disease is caused by T cell sensitisation of the intestine to cereal prolamins, which results in a range of mucosal abnormalities that may lead to malabsorption.1 The population prevalence in western countries is
1 in 200.24 Evidence for an inherited predisposition to coeliac disease comes from studies of first degree relatives of patients and studies of twins.5,6 A strong association is seen between coeliac disease and the HLA-DQ (
1*05, ß1*02) heterodimer (DQ2) which is present in approximately 95% of patients,79 compared with 20-30% of healthy subjects.10,11 The difference in concordance rates between monozygotic twins and HLA identical sibs (80-100% v 25%) implicates non-HLA genes in the genetic predisposition to coeliac disease.11 The overall relative risk in sibs is at least 20 and is therefore four-fold higher than that attributable to HLA alone under model of inheritance.7 Genome linkage searches carried out on Irish,12 Italian,13, and UK14 coeliac
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Eaton, W. W., Byrne, M., Ewald, H., Mors, O., Chen, C.-Y., Agerbo, E., Mortensen, P. B.
(2006). Association of Schizophrenia and Autoimmune Diseases: Linkage of Danish National Registers. Am. J. Psychiatry
163: 521-528
[Abstract] [Full Text] -
Kumar, P J
(2003). European and North American populations should be screened for coeliac disease. Gut
52: 170-171
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
